Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.390
+0.025 (1.06%)
At close: Jun 30, 2025, 4:00 PM
2.440
+0.050 (2.09%)
After-hours: Jun 30, 2025, 4:13 PM EDT
Daré Bioscience Stock Forecast
Stock Price Forecast
The 3 analysts that cover Daré Bioscience stock have a consensus rating of "Strong Buy" and an average price target of $12.5, which forecasts a 423.01% increase in the stock price over the next year. The lowest target is $12 and the highest is $13.
Price Target: $12.5 (+423.01%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 1, 2025.
Analyst Ratings
The average analyst rating for Daré Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +402.09% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +402.09% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +402.09% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +402.09% | Oct 24, 2024 |
| Jones Trading | Jones Trading | Strong Buy Maintains $5 → $13 | Strong Buy | Maintains | $5 → $13 | +443.93% | Aug 16, 2024 |
Financial Forecast
Revenue This Year
9.77M
from 9.78K
Increased by 99,756.91%
Revenue Next Year
21.47M
from 9.77M
Increased by 119.77%
EPS This Year
-2.07
from -0.48
EPS Next Year
-0.99
from -2.07
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.7M | 44.2M | 102.6M | ||
| Avg | 9.8M | 21.5M | 71.6M | ||
| Low | n/a | n/a | 41.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 272,774.1% | 352.5% | 377.7% | ||
| Avg | 99,756.9% | 119.8% | 233.4% | ||
| Low | - | - | 94.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.04 | -0.24 | 0.92 | ||
| Avg | -2.07 | -0.99 | 0.55 | ||
| Low | -2.07 | -2.23 | 0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.